JP2024515697A5 - - Google Patents
Info
- Publication number
- JP2024515697A5 JP2024515697A5 JP2023564480A JP2023564480A JP2024515697A5 JP 2024515697 A5 JP2024515697 A5 JP 2024515697A5 JP 2023564480 A JP2023564480 A JP 2023564480A JP 2023564480 A JP2023564480 A JP 2023564480A JP 2024515697 A5 JP2024515697 A5 JP 2024515697A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- progenitor
- stem
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163178990P | 2021-04-23 | 2021-04-23 | |
| US63/178,990 | 2021-04-23 | ||
| PCT/CA2022/050622 WO2022221962A1 (en) | 2021-04-23 | 2022-04-22 | Stem cells comprising an unrearranged t cell receptor (tcr) gene locus and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515697A JP2024515697A (ja) | 2024-04-10 |
| JP2024515697A5 true JP2024515697A5 (cg-RX-API-DMAC10.html) | 2025-04-30 |
Family
ID=83723544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564480A Pending JP2024515697A (ja) | 2021-04-23 | 2022-04-22 | 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240209314A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4326856A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024515697A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117480249A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3216417A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022221962A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015290554A1 (en) * | 2014-07-18 | 2017-03-09 | Kyoto University | Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells |
| WO2018183823A1 (en) * | 2017-03-31 | 2018-10-04 | Hera Testing Laboratories, Inc. | Novel immunodeficient rat for modeling human cancer |
-
2022
- 2022-04-22 EP EP22790648.4A patent/EP4326856A4/en active Pending
- 2022-04-22 US US18/287,970 patent/US20240209314A1/en active Pending
- 2022-04-22 CN CN202280042484.9A patent/CN117480249A/zh active Pending
- 2022-04-22 JP JP2023564480A patent/JP2024515697A/ja active Pending
- 2022-04-22 WO PCT/CA2022/050622 patent/WO2022221962A1/en not_active Ceased
- 2022-04-22 CA CA3216417A patent/CA3216417A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019204429B2 (en) | Modified hematopoietic stem/progenitor and non-T effector cells, and uses thereof | |
| JP2024054194A5 (cg-RX-API-DMAC10.html) | ||
| Li et al. | Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity | |
| AU2019331866B2 (en) | Car-expressing T cells and car expression vector | |
| Seet et al. | Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids | |
| Graef et al. | Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8+ central memory T cells | |
| Nakazawa et al. | PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor | |
| Lu et al. | Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin | |
| CN114258429A (zh) | 免疫效应细胞工程化和其用途 | |
| JP2021046453A (ja) | 細胞免疫療法のための方法および組成物 | |
| JP2021191294A (ja) | 多能性幹細胞を用いた免疫機能再建法 | |
| JP2022520402A5 (cg-RX-API-DMAC10.html) | ||
| CN111954715A (zh) | 工程改造的免疫效应细胞和其用途 | |
| US9228007B1 (en) | Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells | |
| Selich et al. | Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation | |
| AU2018348142B2 (en) | Cellular reprogramming using temporal and transient plasmid vector expression system | |
| JP2023549098A (ja) | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 | |
| JP2020526194A5 (cg-RX-API-DMAC10.html) | ||
| CN110819596B (zh) | 具有增强的迁移能力的修饰的细胞 | |
| US20220105134A1 (en) | Modified cell and use thereof in gene and cell therapy | |
| JP2020520367A5 (cg-RX-API-DMAC10.html) | ||
| Porter et al. | T-cell reconstitution and expansion after hematopoietic stem cell transplantation:‘T’it up! | |
| WO2021216731A1 (en) | Polyspecific binding molecules and their use in cell therapy | |
| JP2025512886A (ja) | キメラサイトカイン受容体 | |
| US20090217403A1 (en) | Means and methods for generating a t cell against an antigen of interest |